Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours
Metabolites as agents and targets for cancer immunotherapy
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
Multi-faceted influence of immunomodulatory metabolites on CAR-T cell therapy
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
CAR T cells for solid tumors – developments to watch in 2023
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer
Magnesium sensing via LFA-1 regulates CD8+ T cell effector function
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells